Aura Biosciences (AURA) Shareholder's Equity (2020 - 2026)

Aura Biosciences (AURA) Shareholder's Equity (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 7.14 Bn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 595,226.00
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 14.38 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.71 Bn 91.71 Bn - 502.95 Mn
10 Aura Biosciences 412.10 Mn 327.31 Mn - 107.25 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 107.25 Mn
Dec 31, 2025 136.91 Mn
Sep 30, 2025 156.67 Mn
Jun 30, 2025 174.63 Mn
Mar 31, 2025 127.97 Mn
Dec 31, 2024 151.97 Mn
Sep 30, 2024 174.67 Mn
Jun 30, 2024 191.45 Mn
Mar 31, 2024 208.78 Mn
Dec 31, 2023 225.85 Mn
Sep 30, 2023 151.72 Mn
Jun 30, 2023 166.44 Mn
Mar 31, 2023 180.26 Mn
Dec 31, 2022 195.58 Mn
Sep 30, 2022 115.05 Mn
Jun 30, 2022 129.09 Mn
Mar 31, 2022 141.09 Mn
Dec 31, 2021 152.32 Mn
Sep 30, 2021 -131.02 Mn
Jun 30, 2021 -122.75 Mn